AGER and Hyperglycemia: sRAGE levels have been shown to be down-regulated in hyperglycemia and obesity, which has been explained by the beneficial role of sRAGE and its function as decoy to capture the circulating AGEs preventing activation of RAGE signaling pathway as it still possesses the V-ligand essential for ligand binding.